Dart Neuroscience, LLC
Records under this name other than the patents Dart Neuroscience, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 26 patents it holds.
Back to Dart Neuroscience, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,573,937 | Substituted pyridine and pyrazine compounds as PDE4 inhibitors Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,186,582 | Substituted [1,2,4]triazolo[1,5-a]pyrimidin-7-yl Compounds as PDE2 Inhibitors Formerly held In force · High confidence | In force | High confidence | |
| US 10,092,575 | Substituted Thiophene- and Furan-Fused AZOLOPYRIMIDINE-5-(6H)-ONE Compounds Lapsed on the fee record Ended Oct 9, 2026 · Medium confidence | Lapsed on the fee record | Ended Oct 9, 2026 | Medium confidence |
| US 9,963,435 | Compounds for therapeutic use Lapsed on the fee record Ended May 8, 2026 · USPTO record | Lapsed on the fee record | Ended May 8, 2026 | USPTO record |
| US 9,650,349 | Therapeutic isoxazole compounds Lapsed on the fee record Ended May 16, 2025 · USPTO record | Lapsed on the fee record | Ended May 16, 2025 | USPTO record |
| US 7,220,775 | Compound Useful for the Treatment of Neuropathic Pain Formerly held Term ended Term ended Apr 9, 2025 · High confidence | Term ended | Term ended Apr 9, 2025 | High confidence |
| US 8,222,243 | Therapeutic isoxazole compounds Lapsed on the fee record Ended Jul 17, 2024 · USPTO record | Lapsed on the fee record | Ended Jul 17, 2024 | USPTO record |
| US 9,150,572 | Substituted naphthyridine and quinoline compounds as MAO inhibitors Lapsed on the fee record Ended Oct 6, 2023 · USPTO record | Lapsed on the fee record | Ended Oct 6, 2023 | USPTO record |
| US 9,102,674 | Substituted naphthyridine and quinoline compounds as MAO inhibitors Lapsed on the fee record Ended Aug 11, 2023 · USPTO record | Lapsed on the fee record | Ended Aug 11, 2023 | USPTO record |
| US 7,919,626 | Pyrazole compounds and uses thereof Formerly held Lapsed on the fee record Ended Apr 5, 2023 · USPTO record | Lapsed on the fee record | Ended Apr 5, 2023 | USPTO record |